TrialRheumatology (Oxford, England)2024

The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.

Herbert S B Baraf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.